Peer-influenced content. Sources you trust. No registration required. This is HCN.
Consultant360
“Today’s approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment.” – Iilun Murphy, MD, Director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research
Allergy & Immunology March 12th 2026
Medical Professionals Reference (MPR)
64% of those who self-administered Cardamyst converted to sinus rhythm within 30 minutes compared with 31% who received placebo.
Cardiology February 10th 2026
MDLinx
“The key word is association. This study does not establish causality. For absolute, catastrophic harm to an appropriately selected, monitored pain patient, the risk is small.” – Sean Mackey, MD, PhD, Chief of the Division of Stanford Pain Medicine
Clinical Pharmacology February 6th 2026
Epoch Health
Clinicians often are unaware that gabapentinoids can cause peripheral edema or even respiratory depression.
Clinical Pharmacology February 4th 2026
“The pharmacist should have realized that the prescription was incorrectly written and should have communicated with the provider, who would have then understood that the titration schedule was incorrect, and all this wouldn’t have happened.”
Clinical Pharmacology December 11th 2025
Pharmacy Learning Network
“Pharmacies exist to heal the sick, not to fuel addiction and line the pockets of drug traffickers.” – DEA Administrator Terrance Cole